Antitrust Issues in the Food Industry During the Pandemic
Hear a discussion on antitrust issues in the food industry amidst the COVID-19 pandemic.
The Failing Firm Antitrust Defense – How To Navigate Financially Troubled Mergers During a Pandemic
Hear antitrust issues merging firms may face when at least one is failing in the midst of a pandemic.
Equity Markets and the COVID-19 Pandemic
Hear a discussion with high-profile executives on market challenges during the COVID-19 crisis.
Leveraging Business Model Uncertainty to Drive Digital Transformation and Smart Data Strategies
Listen to the legal implications surrounding COVID-19 for business leaders.
Accelerate: Getting to Your North Star Faster
Listen to the legal implications surrounding COVID-19 for business leaders.
How to Pivot and Transform Your Digital Assets into Alternate Revenue Streams
Listen to the legal implications surrounding COVID-19 for business leaders.
Positioning for What's Beyond the Horizon: What Digital Transformation and The Data Economy Mean for You
Listen to the legal implications surrounding COVID-19 for business leaders.
Fraud and Government Enforcement in Times of Crisis
Listen to a discussion on the topic of lessons learned from past crises.
Marketing, Promoting and Pricing Your Products During the Pandemic
Hear a discussion on several trending marketing, promotion and pricing issues.
Fed-Backed Credit Facilities From the CARES Act: Implications for Businesses
Hear a discussion on what has been made available to businesses and other entities through the CARES Act.
Corporate Disclosure and Enforcement Impact of COVID-19 on SEC Filings
Hear from former SEC staff on latest guidance from the divisions of Corporation Finance and Enforcement.
COVID-19 Pandemic: Antitrust Risks and Possible Protection Under the Defense Production Act and State Action Immunity Doctrine
Hear the criminal and civil antitrust risks and best practices businesses can follow to protect themselves.
$2 Trillion CARES Act Provides Significant Tax and Workforce Relief for Businesses, Individuals
Hear an analysis of the $2 trillion CARES Act, which was signed by President Trump on March 27, 2020.